Señales en vivo de MRK | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 16:03):

Stats
Volumen de hoy	6.55M
Volumen promedio	8.23M
Capitalización de mercado	323.09B
EPS	$0.0300 ( 2024-04-25 )
Próxima fecha de ganancias	( $1.870 ) 2024-05-28
Last Dividend	$0.770 ( 2023-12-14 )
Next Dividend	$0 ( N/A )
P/E	140.19
ATR14	$0.0390 (0.03%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-04	Smart Dalton	Buy	612	Common Stock
2024-05-03	Smart Dalton	Buy	1 530	Common Stock
2024-05-04	Smart Dalton	Sell	302	Common Stock
2024-05-03	Smart Dalton	Sell	590	Common Stock
2024-05-03	Smart Dalton	Buy	516	Common Stock

INSIDER POWER
25.86
Last 99 transactions
Buy: 1 325 861 \| Sell: 852 034

Volumen Correlación

Largo: 0.06 (neutral)

Corto: 0.92 (very strong)

Signal:(59.144) Expect same movement, but be aware

Merck & Co Inc Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Merck & Co Inc Correlación - Moneda/Commodity

-0.36
( neutral )

-0.34
( neutral )

0.00
( neutral )

-0.54
( weak negative )

0.57
( weak )

-0.43
( neutral )

Merck & Co Inc Finanzas

Annual	2023
Ingresos:	$59.87B
Beneficio Bruto:	$43.89B (73.31 %)
EPS:	$0.140

FY	2023
Ingresos:	$59.87B
Beneficio Bruto:	$43.89B (73.31 %)
EPS:	$0.140

FY	2022
Ingresos:	$59.28B
Beneficio Bruto:	$41.87B (70.63 %)
EPS:	$5.73

FY	2021
Ingresos:	$48.70B
Beneficio Bruto:	$35.08B (72.02 %)
EPS:	$5.16

Financial Reports:

No articles found.

Merck & Co Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.690 (N/A)	$0.730 (N/A)	$0.730 (N/A)	$0.730 (N/A)	$0.730 (N/A)	$0.770 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Merck & Co Inc Dividend Information - Dividend King

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.58 - Stable (31.51%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.00663	1970-06-02
Last Dividend	$0.770	2023-12-14
Next Dividend	$0	N/A
Payout Date	2024-01-08
Next Payout Date	N/A
# dividends	214	--
Total Paid Out	$52.58	--
Avg. Dividend % Per Year	2.07%	--
Score	6.02	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.58
Div. Directional Score	8.99	--

Next Divdend (Est)
(2024-07-08)

$0.776 Estimate 39.86 %

Dividend Stability

0.80 Good

Dividend Score

6.02

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1970	$0.0206	1.40%
1971	$0.0292	2.31%
1972	$0.0224	1.35%
1973	$0.0327	1.36%
1974	$0.0278	1.31%
1975	$0.0371	2.09%
1976	$0.0378	2.04%
1977	$0.0411	2.31%
1978	$0.0465	3.27%
1979	$0.0530	2.94%
1980	$0.0628	3.34%
1981	$0.0702	3.08%
1982	$0.0744	3.28%
1983	$0.0757	3.39%
1984	$0.0809	3.37%
1985	$0.0875	3.54%
1986	$0.106	2.90%
1987	$0.143	2.14%
1988	$0.208	2.38%
1989	$0.274	3.01%
1990	$0.321	2.57%
1991	$0.378	2.66%
1992	$0.458	1.73%
1993	$0.506	2.42%
1994	$0.554	3.29%
1995	$0.610	3.34%
1996	$0.706	2.30%
1997	$0.830	2.18%
1998	$0.946	1.84%
1999	$1.070	1.50%
2000	$1.202	1.86%
2001	$1.316	1.48%
2002	$1.356	2.38%
2003	$4.14	7.45%
2004	$1.432	3.19%
2005	$1.452	4.87%
2006	$1.452	4.65%
2007	$1.452	3.46%
2008	$1.452	2.65%
2009	$1.452	4.91%
2010	$1.452	4.11%
2011	$1.490	4.33%
2012	$1.613	4.41%
2013	$1.650	4.18%
2014	$1.689	3.58%
2015	$1.726	3.16%
2016	$1.765	3.52%
2017	$1.802	3.14%
2018	$1.899	3.54%
2019	$2.16	2.99%
2020	$2.37	2.69%
2021	$2.61	3.38%
2022	$2.80	3.64%
2023	$2.96	2.66%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50
SJT	Dividend Royal	2023-11-29	Monthly	39	12.52%	8.50
ORC	Dividend Royal	2023-11-29	Monthly	12	9.23%	8.50
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0375	1.500	9.25	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0218	1.200	9.27	10.00	[0 - 0.3]
returnOnEquityTTM	0.0584	1.500	-0.462	-0.693	[0.1 - 1]
payoutRatioTTM	2.42	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	1.253	0.800	8.74	6.99	[1 - 3]
quickRatioTTM	0.728	0.800	-0.421	-0.337	[0.8 - 2.5]
cashRatioTTM	0.226	1.500	9.86	10.00	[0.2 - 2]
debtRatioTTM	0.323	-1.500	4.61	-6.92	[0 - 0.6]
interestCoverageTTM	7.47	1.000	8.34	8.34	[3 - 30]
operatingCashFlowPerShareTTM	5.83	2.00	8.06	10.00	[0 - 30]
freeCashFlowPerShareTTM	4.36	2.00	7.82	10.00	[0 - 20]
debtEquityRatioTTM	0.848	-1.500	6.61	-9.91	[0 - 2.5]
grossProfitMarginTTM	0.747	1.000	0.889	0.889	[0.2 - 0.8]
operatingProfitMarginTTM	0.110	1.000	9.80	9.80	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.431	1.000	8.72	8.72	[0.2 - 2]
assetTurnoverTTM	0.580	0.800	9.46	7.57	[0.5 - 2]
Total Score				11.41

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	140.13	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.0584	2.50	-0.297	-0.693	[0.1 - 1.5]
freeCashFlowPerShareTTM	4.36	2.00	8.55	10.00	[0 - 30]
dividendYielPercentageTTM	2.35	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	5.83	2.00	8.06	10.00	[0 - 30]
payoutRatioTTM	2.42	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	4.77	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.240	1.000	6.49	0	[0.1 - 0.5]
Total Score				6.58

Merck & Co Inc

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.